ViVE 2025 – Panda Health
Michael Blumenthal from Hyro joins the ViVE show floor to discuss the emerging role of AI in healthcare. She highlights how Hyro is not just talking about AI’s potential but is actively deploying it with healthcare organizations, delivering impactful results. Michael emphasizes Hyro’s success in integrating deeply into the healthcare community, focusing solely on healthcare’s…
Latest
Healthcare
Joshua Titus with Gozio
Joshua from Gozeo joins Amy on Panda Perspectives to discuss how Gozeo is personalizing the patient experience through mobile solutions. Gozeo, a healthcare IT company, serves as a digital front door for health systems, helping engage patients, visitors, and staff. Joshua highlights the growing trend of personalization in healthcare, emphasizing how mobile platforms can tailor…
Healthcare
Scott North with Praia Health
Scott North, Head of Partnerships at Praia Health, joins Panda Perspectives to discuss how Praia is redefining patient experience orchestration. Spun out of Providence in 2023, Praia helps health systems retain patients by unifying fragmented experiences—like lab visits and pharmacy trips—into a single, seamless journey. Scott emphasizes Praia’s focus on long-term engagement, reducing patient leakage,…
Healthcare
Linda Stevenson with Fisher-Titus Health
Linda Stevenson, CIO of Fisher-Titus, shares why she helped launch the rural health community initiative at CHIME and how it’s creating essential momentum for collaboration. Speaking from VIVE 2025, Linda highlights the unique challenges rural hospitals face—from limited budgets to lean staffing—and the importance of collective action. She emphasizes how vendor education is key: once…
Healthcare
Nayan Patel with Upson Regional Medical Center
Nayan Patel, CIO of Upson Regional Medical Center, reflects on the unique challenges and opportunities rural hospitals face in today’s healthcare climate. Speaking from VIVE 2025, he highlights how tighter margins and staffing constraints push rural leaders to be incredibly strategic—often favoring cost-saving innovations and maximizing existing vendor capabilities over chasing new tech. Despite resource…
Healthcare
Josh Newman with John Hopkins Medicine
Josh Newman, VP of Clinical Systems at Johns Hopkins, shares how his team is embracing AI to reduce clinician burnout and reshape health IT delivery. At VIVE 2025, he reflects on their successful DAX pilot and the excitement it’s generated among providers—marking a rare IT win that clinicians actually celebrate. Josh discusses the new mindset…
Healthcare
Faith Balaban with Montage Health
Faith Balaban, Human Experience Manager at Montage Health, shares how her team is leveraging AI and digital health innovation to elevate care and operational efficiency. From piloting ambient documentation tools like DAX to scaling remote patient monitoring, Faith highlights how Montage Health is addressing workforce burnout and improving patient outcomes. She discusses the growing role…
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
